Leon Wang
Stock Analyst at Barclays
(3.67)
# 872
Out of 4,479 analysts
11
Total ratings
71.43%
Success rate
21.16%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Overweight | $40 → $63 | $64.50 | -2.33% | 5 | May 29, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Equal-Weight | $13 → $4 | $2.79 | +43.37% | 3 | May 10, 2024 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Equal-Weight | $41 → $59 | $40.15 | +46.95% | 3 | Sep 12, 2023 |
Insmed
May 29, 2024
Maintains: Overweight
Price Target: $40 → $63
Current: $64.50
Upside: -2.33%
RAPT Therapeutics
May 10, 2024
Downgrades: Equal-Weight
Price Target: $13 → $4
Current: $2.79
Upside: +43.37%
MoonLake Immunotherapeutics
Sep 12, 2023
Maintains: Equal-Weight
Price Target: $41 → $59
Current: $40.15
Upside: +46.95%